Neurotrophic Keratitis Market Size
Market Size in USD Mn
CAGR9.2%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 9.2% |
| Market Concentration | High |
| Major Players | RegeneRx Biopharmaceuticals, Inc., Dompé Farmaceutici S.p.A, Aldeyra Therapeutics, ReGenTree LLC, Oxurion NV and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Neurotrophic Keratitis Market Analysis
The neurotrophic keratitis market is estimated to be valued at USD 185.6 Mn in 2024 and is expected to reach USD 343.3 Mn by 2031, growing at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031. The neurotrophic keratitis market is witnessing significant growth owing to rising incidence of ocular disorders, growing geriatric population, and technological advancements in drug delivery methods.